Unified pipeline tracking, KOL network mapping, prescriber segmentation, and drug safety signals — powered by ClinicalTrials.gov, PubMed, CMS, FDA FAERS, and 10+ federal data sources.
No login required. Live demo with real data.
65K+
Oncology Trials
405K+
Publications
179
Drugs Monitored
18
Indications
ClinicalTrials.gov
65,000+ oncology trials
PubMed
405K+ publications
CMS Open Payments
$126M+ industry payments
NPI Registry
4,700+ oncology providers
CMS Medicare
Part B & Part D spending
FDA FAERS
179 drugs, adverse events
FDA Orange Book
Patent & exclusivity data
FDA Purple Book
Biosimilar products
openFDA
174 drug labels
SEC EDGAR
Sponsor financials
Purpose-built analytics for every stage of the oncology commercial lifecycle.
Pipeline & Publication Analytics
Monitor clinical trial activity, track sponsor pipelines, analyze publication trends, and map competitive landscapes across any oncology indication.
HCP Clustering & Targeting
K-means segmentation on prescriber populations using payment patterns, publication records, and trial participation. Actionable channel allocation.
KOL Influence Mapping
Graph analytics mapping opinion leader networks through co-authorship, co-investigation, and payment patterns. PageRank centrality and community detection.
Drug Safety & Market Intelligence
FDA FAERS adverse event analysis across 179 oncology drugs, CMS drug economics, prescriber analytics, FDA labels, and patent exclusivity landscape.
See the platform in action or reach out to discuss your team's needs.